Tackling the high price of specialty drugs, California's Obamacare exchange capped what consumers will have to pay for expensive medications each month.
Under fire for selling a medical scope linked to superbug outbreaks, Olympus Corp. is pushing back against its critics and says the design of its product isn't necessarily the sole cause for infections.
A federal panel concluded Friday that the medical scopes linked to a deadly string of superbug outbreaks are unsafe as designed and urged the U.S. Food and Drug Administration to do more to protect patients.
Patients across the nation continue to face considerable risk from medical scopes linked to deadly bacterial outbreaks due to basic design flaws and a lack of easy fixes, a federal panel was warned Thursday.
Olympus Corp. and two other manufacturers of medical scopes linked to a string of superbug outbreaks declined to speak Thursday at a Food and Drug Administration hearing on the deadly problem.
Three months after deadly superbug outbreaks sparked alarm nationwide, U.S. hospitals are still searching for how best to clean a controversial medical scope and keep patients safe.
After using most of $1 billion in federal start-up money, California's Obamacare exchange is preparing to go on a diet.
A Seattle hospital hit by a superbug outbreak is teaming up with a patient's family and accusing Olympus Corp. of selling a defective medical scope prone to spreading deadly bacteria.